Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT010 in healthy Japanese adults
NCT02197975Phase 1Completed
- Sponsor
- Pearl Therapeutics
- Start
- Aug 2014
- Primary completion
- Oct 2014
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Breztri Aerosphere in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Pearl Therapeutics. Primary endpoint: Pharmacokinetic profile at 12 hours. Started Aug 2014; status: completed.
02
Drugs
Breztri Aerosphere
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02197975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02197975.